Show simple item record

dc.contributor.editorGaxiola, Efrain
dc.date.accessioned2021-04-20T15:31:28Z
dc.date.available2021-04-20T15:31:28Z
dc.date.issued2012
dc.identifierONIX_20210420_9789535105619_1366
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/66008
dc.description.abstractAtherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The complex and intimate relationship between atherothrombosis and traditional and novel risk factors is discussed in the following chapters of Traditional and Novel Risk Factors in Atherothrombosis - from basic science to clinical and therapeutic concerns. Beginning with pathology and pathophysiology of atherothrombosis, plaque rupture/disruption, this book continues with molecular, biochemical, inflammatory, cellular aspects and finally analyzes several aspects of clinical pharmacology.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicineen_US
dc.subject.otherCardiovascular medicine
dc.titleTraditional and Novel Risk Factors in Atherothrombosis
dc.typebook
oapen.identifier.doi10.5772/1062
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789535105619
oapen.relation.isbn9789535169826
oapen.imprintIntechOpen
oapen.pages154


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/3.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/3.0/